enGene Therapeutics Inc.

ENGN · XNAS

CIK 1980845fmd_11GYM23DKG83G0CN0EB7B5NRKZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Nov 01, 2021 to Jul 31, 2026, 16 periods

Ratios computed from the standardized statements. Select a value to open its proof.